Development and Validation of Models to Predict Functional Cure in Patients With CHB After Peg-IFN Based Therapy

NCT06196632 · clinicaltrials.gov ↗

UNKNOWN

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: Peginterferon-α; Nucleoside analogs

Sponsor

Qilu Hospital of Shandong University